Taconic Capital Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-900,000
Closed -$21.7M 106
2014
Q2
$21.7M Buy
+900,000
New +$9.38M 0.95% 35

Taconic Capital Advisors's IDIX Position: Q3 2014 in Review

Taconic Capital Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 900,000 shares — an estimated $21.7M sold.

Taconic Capital Advisors first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $21.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Taconic Capital Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Taconic Capital Advisors sold 900,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $21.7M.
  • Taconic Capital Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Taconic Capital Advisors's IDENIX PHARMACEUTICALS INC position peaked at $21.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Taconic Capital Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.